SEC Form D · filed February 16, 2021
Gila Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (13)
Jon J. Freeman · Minneapolis, MNExecRichard J. Horan · Minneapolis, MNDirectorChristopher J. De Souza · Minneapolis, MNDirectorTom Vasicek · Minneapolis, MNExecSteve Jaffee · Cincinnati, OHExecJames Geiskopf · LOS ANGELES, CADirectorEdmund B. Moy · LOS ANGELES, CADirectorScott Schorer · Boston, MAExec · DirectorNick Parkes · Luxembourg, LuxembourgDirectorDavid Redmond · Luxembourg, LuxembourgDirectorMatthew Perelman · NEW YORK, NYExecTom Vasicek · Minneapolis, MNExecScott Schorer · Boston, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗